Patent Ductus Arteriosus
Last Posted: Sep 20, 2021
- Evaluation of urinary acetaminophen metabolites and its association with the genetic polymorphisms of the metabolizing enzymes, and serum acetaminophen concentrations in preterm neonates with patent ductus arteriosus.
Sridharan Kannan, et al. Xenobiotica; the fate of foreign compounds in biological systems 2021 9 1-32
- Association analysis of maternal MTHFR gene polymorphisms and the occurrence of congenital heart disease in offspring.
Sun Mengting, et al. BMC cardiovascular disorders 2021 6 (1) 298
- Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
He Xin, et al. Advances in therapy 2020 11
- Association between 5,10-methylenetetrahydrofolate, gene polymorphism and congenital heart disease.
Wang H L, et al. Journal of biological regulators and homeostatic agents 0 0 (5) 1255-1260
- Can Functional Polymorphisms in VEGF and MMP Predict Intraventricular Hemorrhage in Extremely Preterm Newborns?
Prasun Pankaj, et al. Developmental neuroscience 2018 0 (4) 337-343
- Genetic variants associated with patent ductus arteriosus in extremely preterm infants.
Dagle John M, et al. Journal of perinatology : official journal of the California Perinatal Association 2019 3 (3) 401-408
- Vascular endothelial growth factor polymorphism rs2010963 status does not affect patent ductus arteriosus incidence or cyclooxygenase inhibitor treatment success in preterm infants.
Sallmon Hannes, et al. Cardiology in the young 2019 6 1-5
- Association of NKX2-5, GATA4, and TBX5 polymorphisms with congenital heart disease in Egyptian children.
Behiry Eman G, et al. Molecular genetics & genomic medicine 2019 3 e612
- Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations.
Regalado Ellen S et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 20(10) 1206-1215
- Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.
Thomford Nicholas Ekow et al. Omics : a journal of integrative biology 2018 May 22(5) 301-321
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.